Merck KGaA to Buy Sigma-Aldrich for to Add Chemicals

Merck KGaA agreed to buy Sigma-Aldrich Corp. for $17 billion in cash to expand in chemicals used in research labs and pharmaceutical manufacturing and reduce its dependence on drug development.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.